Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

CRISPR/Cas “non-target” sites inhibit on-target cutting rates

View through CrossRef
Abstract CRISPR/Cas systems have become ubiquitous for genome editing in eukaryotic as well as bacterial systems. Cas9 associated with a guide RNA (gRNA) searches DNA for a matching sequence (target site) next to a protospacer adjacent motif (PAM) and once found, cuts the DNA. The number of PAM sites in the genome are effectively a non-target pool of inhibitory substrates, competing with the target site for the Cas9/gRNA complex. We demonstrate that increasing the number of non-target sites for a given gRNA reduces on-target activity in a dose dependent manner. Furthermore, we show that the use of Cas9 mutants with increased PAM specificity towards a smaller subset of PAMs (or smaller pool of competitive substrates) improves cutting rates. Decreasing the non-target pool by increasing PAM specificity provides a path towards improving on-target activity for slower high fidelity Cas9 variants. These results demonstrate the importance of competitive non-target sites on Cas9 activity and, in part, may help to explain sequence and context dependent activities of gRNAs. Engineering improved PAM specificity to reduce the competitive non-target pool offers an alternative strategy to engineer Cas9 variants with increased specificity and maintained on-target activity. Highlights The pool of non-target PAM sites inhibit Cas9/gRNA on-target activity non-target PAM inhibition is dose dependent non-target PAM inhibition is a function of gRNA sequence non-target PAM inhibition is a function of Cas9 levels
Title: CRISPR/Cas “non-target” sites inhibit on-target cutting rates
Description:
Abstract CRISPR/Cas systems have become ubiquitous for genome editing in eukaryotic as well as bacterial systems.
Cas9 associated with a guide RNA (gRNA) searches DNA for a matching sequence (target site) next to a protospacer adjacent motif (PAM) and once found, cuts the DNA.
The number of PAM sites in the genome are effectively a non-target pool of inhibitory substrates, competing with the target site for the Cas9/gRNA complex.
We demonstrate that increasing the number of non-target sites for a given gRNA reduces on-target activity in a dose dependent manner.
Furthermore, we show that the use of Cas9 mutants with increased PAM specificity towards a smaller subset of PAMs (or smaller pool of competitive substrates) improves cutting rates.
Decreasing the non-target pool by increasing PAM specificity provides a path towards improving on-target activity for slower high fidelity Cas9 variants.
These results demonstrate the importance of competitive non-target sites on Cas9 activity and, in part, may help to explain sequence and context dependent activities of gRNAs.
Engineering improved PAM specificity to reduce the competitive non-target pool offers an alternative strategy to engineer Cas9 variants with increased specificity and maintained on-target activity.
Highlights The pool of non-target PAM sites inhibit Cas9/gRNA on-target activity non-target PAM inhibition is dose dependent non-target PAM inhibition is a function of gRNA sequence non-target PAM inhibition is a function of Cas9 levels.

Related Results

Résumés des conférences JRANF 2021
Résumés des conférences JRANF 2021
able des matières Résumés. 140 Agenda Formation en Radioprotection JRANF 2021 Ouagadougou. 140 RPF 1 Rappel des unités de doses. 140 RPF 2 Risques déterministes et stochastique...
Introduction to CRISPR/Cas9
Introduction to CRISPR/Cas9
Clustered Regularly Interspersed Short Palindromic Repeats (often referred to as CRISPR) is a revolutionary new genome engineering technology that is capable of modifying virtually...
Genome engineering using CRISPR
Genome engineering using CRISPR
Clustered Regularly Interspersed Short Palindromic Repeats (often referred to as CRISPR) is a revolutionary new genome engineering technology that is capable of modifying virtually...
Epidemiological and evolutionary consequences of CRISPR-Cas reactivity
Epidemiological and evolutionary consequences of CRISPR-Cas reactivity
Abstract Adaptive immune systems face a control challenge: they should react with enough strength to clear an infection while avoiding to harm their organism. CRISP...
Gold Nanomaterials‐Implemented CRISPR‐Cas Systems for Biosensing
Gold Nanomaterials‐Implemented CRISPR‐Cas Systems for Biosensing
AbstractDue to their superiority in the simple design and precise targeting, clustered regularly interspaced short palindromic repeats (CRISPR)‐Cas systems have attracted significa...
Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics
Since the onset of the COVID-19 pandemic, a variety of diagnostic approaches, including RT-qPCR, RAPID, and LFA, have been adopted, with RT-qPCR emerging as the gold standard. Howe...
Expanding the Microbial Genomic Landscape and Biotechnological Applications of CRISPR-Cas Systems
Expanding the Microbial Genomic Landscape and Biotechnological Applications of CRISPR-Cas Systems
The CRISPR-Cas systems, identified initially as adaptive immune mechanisms in bacteria and archaea against viral threats, have rapidly evolved into transformative tools in genetic ...
Structural and Biochemical Insights into CRISPR-Cas Nucleases for Therapeutic Genome Editing
Structural and Biochemical Insights into CRISPR-Cas Nucleases for Therapeutic Genome Editing
CRISPR-Cas nucleases have changed the world of genetic editing because they provides specific, programmable and scalable editing possibilities. These RNA-guided nucleases were firs...

Back to Top